Humana Inc. (NYSE:HUM) Position Increased by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans boosted its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 639.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 385,782 shares of the insurance provider’s stock after acquiring an additional 333,636 shares during the quarter. Thrivent Financial for Lutherans owned 0.32% of Humana worth $144,147,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Pzena Investment Management LLC lifted its stake in shares of Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the last quarter. Sanders Capital LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $489,300,000. Ontario Teachers Pension Plan Board grew its position in Humana by 11,647.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after acquiring an additional 1,050,459 shares during the last quarter. Putnam Investments LLC boosted its stake in Humana by 550.3% in the fourth quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after purchasing an additional 740,858 shares in the last quarter. Finally, Steadfast Capital Management LP bought a new stake in Humana during the 1st quarter worth about $158,813,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on HUM shares. Oppenheimer boosted their target price on Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. TD Cowen upped their price objective on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Morgan Stanley initiated coverage on Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 target price on the stock. Finally, Royal Bank of Canada boosted their price objective on shares of Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, September 5th. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $398.70.

View Our Latest Stock Analysis on Humana

Humana Trading Down 0.5 %

Shares of HUM stock opened at $310.41 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The firm has a 50 day moving average price of $357.71 and a two-hundred day moving average price of $345.63. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $530.54. The company has a market capitalization of $37.40 billion, a PE ratio of 19.33, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $8.94 earnings per share. As a group, analysts predict that Humana Inc. will post 16 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.14%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.